Electric breast pump
DeviceParticipants randomized to the intrapartum nipple stimulation will use electric breast pump or nipple stimulate by hand (if preferred) (intervention) to induce labor for at least 2 hours
NCT Number: NCT05079841
The investigators propose a parallel group randomized clinical trial of intrapartum nipple stimulation versus exogenous oxytocin infusion for nulliparous women undergoing induction of labor near term. The central hypothesis is that intrapartum nipple stimulation to induce labor increases spontaneous vaginal delivery, improves patient-centered outcomes such as childbirth satisfaction, labor agentry, and pain scores, and reduces adverse neonatal and maternal outcomes in nulliparous women. The investigators will pursue the following specific aims: 1) Assess the effectiveness of intrapartum nipple stimulation on the rate of spontaneous vaginal delivery in nulliparous women, 2) Breastfeeding as the sole source of nutrition at time of maternal hospital discharge (Primary Aims); 3) Maximal percent newborn weight loss during the birth hospitalization within 72 hours of life, 4) Determine the effect of intrapartum nipple stimulation on the rate of adverse maternal and neonatal outcomes, 5) Determine the impact of intrapartum nipple stimulation on patient-centered outcomes and 6) In a sub-cohort of women who are enrolled in the trial, investigators will measure the change in oxytocin concentration from baseline to time at which patient achieves a regular contraction pattern.
Interested in participating?
Request Info18 year and older
Female
Interventional
Phase 4
Yale New Haven Hospital, New Haven, Connecticut, United States
Primary Objectives
Secondary Objectives (if applicable)
The secondary objectives are as follows:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants randomized to the intrapartum nipple stimulation will use electric breast pump or nipple stimulate by hand (if preferred) (intervention) to induce labor for at least 2 hours
Participants randomized to the standard care arm will use exogenous oxytocin intravenous infusion to induce labor as current standard of care
Other names: Pitocin intravenous infusion
Time frame: At delivery
Spontaneous vaginal delivery will be defined as delivery that occurs without the use of forceps, vacuum, or cesarean
Time frame: up to 72 hours following delivery
Number of participants using breastfeeding as the sole source of nutrition (BSSN) at time of maternal discharge or 72 hours of life (whichever is sooner)
Time frame: At delivery
Delivery with the assistance of forceps or vacuum, and indication
Time frame: At delivery
Delivery by cesarean section
Time frame: At delivery
Time interval from randomization to delivery
Time frame: From delivery to 24 hours postpartum
Cumulative blood loss of ≥1,000 mL within 24 hours after the birth process
Time frame: From delivery to 24 hours postpartum
Transfusion; non-elective hysterectomy; use of ≥2 uterotonic medications other than oxytocin; other interventions such as uterine compression sutures, uterine artery ligation or embolization, hypogastric artery ligation, balloon tamponade
Time frame: 3-7 days postpartum
Suspected intraamniotic infection, intrapartum chorioamnionitis, or postpartum endometritis (defined as maternal fever ≥38° Fahrenheit with planned or initiated administration of therapeutic antibiotics) after randomization and prior to delivery hospitalization discharge
Time frame: After delivery to 12 weeks postpartum
Subject-reported occurrence of lactational mastitis
Time frame: immediately prior to up to immediately post delivery
Incidence of maternal death prior to, during, or post delivery
Time frame: 3-7 days postpartum
Any admission to the Intensive Care Unit after delivery and prior to delivery hospitalization discharge
Time frame: up to 28 days following birth
Any admission to the Neonatal Intensive Care Unit From birth to birth hospitalization discharge or 28 days after birth, whichever is earlier
Time frame: At 5 minutes after birth
The Neonatal Apgar score is scored from 0 to 10. A 5-minute Apgar score of 0-3 correlates with neonatal mortality in large population studies.
Time frame: At delivery
Umbilical cord arterial pH <7.0 or base excess >12 mmol/L; or umbilical cord venous pH <7.0 or base excess >12 mmol/L if arterial blood sample not available
Time frame: up to 28 days following delivery
Intrapartum fetal death or neonatal death; cardiorespiratory support within first 72 hours of life; neonatal encephalopathy; seizures; hypothermic treatment (cooling); sepsis; pneumonia; major birth injury; meconium aspiration syndrome; intracranial hemorrhage or subgaleal hemorrhage; or hypotension requiring pressor support
Time frame: At 72 hours of life or birth hospitalization discharge, whichever is earlier
Maximal percent newborn weight loss in kilograms(kg)
Time frame: At intervention start and than again 2 hours after intervention start
Visual analog scale, scored with Likert scale from 0 (no pain) to 10 (worst pain)
Time frame: 6-96 hours after delivery
Birth Satisfaction Scale-Revised (BSS-R) is a 10-item self-report valid and reliable measure (scores range from 0 to 40, 0 being the least satisfaction and 40 being the most satisfaction)
Time frame: 6-96 hours after delivery
Labor Agentry Scale is a 29-item survey designed to assess expectations and experiences of personal control during childbirth (scores range from 29 to 203, with higher scores indicating greater perceived control during childbirth)
Time frame: 4 to 12 weeks after delivery
Edinburgh Postnatal Depression Scale is a 10-item self report scored from 0 to 30; score >10 warrants additional clinical assessment for depression
Time frame: 4 to 12 weeks after delivery
Maternal Breastfeeding Evaluation Scale (MBES) is a 30-item using a 5-point Likert scale with higher scores reflecting more positive breastfeeding experiences.
Time frame: From randomization to hospital discharge, approximately 3-7 days
Participants ability to express and/or collect colostrum and/or breastmilk intrapartum
Time frame: 2 weeks postpartum
Subject-reported perception of milk supply using the validated Perception of Insufficient Milk Supply (PIMS). PIM is defined as a state in which a mother has or perceives that she has an inadequate supply of breast milk to meet her infant's needs. A perception of insufficient milk supply is associated with early discontinuation of breastfeeding.
Contact information is provided by the study sponsor or research team.
Moeun Son, MD, MSCI
CONTACT
Molly McAdow, MD, PhD
CONTACT
Yale University
Other
The Stimulation To Induce Mothers (STIM) Study: A Parallel Group Randomized Controlled Trial
Acronym: STIM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04551482
Body Weight, Nutrition Disorders
Boston, Massachusetts, United States
View Trial DetailsNCT07351799
Anxiety, Anxiety Disorders
Rochester, Minnesota, United States
View Trial DetailsNCT07566455
Female Urogenital Diseases and Pregnancy Complications, Hemorrhage
Multan, Punjab Province, Pakistan
View Trial DetailsNCT04760496
Body Weight, Nutrition Disorders
Angers, France
View Trial Details